| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.21 | 0.1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |